Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140

British Journal of Pharmacology

Volumn 108, Issue 2, 1993, Pages 405-411

  Griesbacher, Thomas ^a   Tiran, Beate ^a   Lembeck, Fred ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

amylase; Bradykinin antagonists; caerulein; Hoe 140; hypovolaemia; lipase; pancreatitis (experimental); plasma protein extravasation; protease inhibitors; trypsin

Indexed keywords

AMYLASE; APROTININ; CAPTOPRIL; CERULETIDE; ICATIBANT; SOYBEAN TRYPSIN INHIBITOR; TRIACYLGLYCEROL LIPASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EDEMA; ENZYME ACTIVITY; EXTRAVASATION; HEMATOCRIT; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ACUTE DISEASE; ANIMAL; BRADYKININ; COMPARATIVE STUDY; EDEMA; FEMALE; HEMATOCRIT; HYPOTENSION; PANCREAS; PANCREATITIS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T;

EID: 0027475567     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1993.tb12817.x     Document Type: Article

References (31)

1. Experimental models and concepts in acute pancreatitis
2. Experimental acute pancreatitis. I. Hypotensive effect induced by pancreatic exudate
3. Objectification of the severity of acute pancreatitis
4. Aetiology and pathogenesis of pancreatitis
5. Demonstration and characterization of the hemoconcentrating effect of ascitic fluid that accumulates during hemorrhagic pancreatitis
6. Zur Frage des Entstehungsmechanismus des Kreislaufkollapses bei der akuten Pankreasnekrose
7. Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin
8. Structural alterations of pancreatic microvasculature in cerulein‐induced pancreatitis in the rat
9. Effects of the bradykinin antagonist, Hoe 140, in experimental acute pancreatitis
10. Analysis of the antagonistic actions of HOE 140 and other novel bradykinin analogues on the guinea‐pig ileum
11. Treatment of experimental acute pancreatitis by the bradykinin antagonist HOE 140
12. Clinical trial with a protease inhibitor gabexate medsilate in acute pancreatitis
13. Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studies
14. New, long‐acting, potent bradykinin antagonists
15. Hemorrhagic pancreatitis
16. Formation and destruction of plasma kinins during experimental acute hemorrhagic pancreatitis in dogs
17. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venom and by trypsin
18. Role of bradykinin in the development of acute pancreatitis
19. Subcellular redistribution of lysosomal enzymes during caerulein‐induced pancreatitis
20. Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues
21. Treatment of acute pancreatitis; comparison of animal and human studies
22. A controlled trial of trasylol in the treatment of acute pancreatitis
23. Kallikrein inhibitors
24. Metabolism of bradykinin and bradykinin analogs
25. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis
26. Zur Frage der Therapie der Pankreatitis
27. Caerulein‐induced acute pancreatitis in rats: changes in glycoprotein‐composition of subcellular membrane systems in acinar cells
28. Hoe 140 a new potent and long acting bradykinin‐antagonist: in vivo studies
29. Cholecystokinin antagonists
30. Activation of proteases in cerulein‐induced pancreatitis